Millennium Management
CBAY

Millennium Management’s Cymabay Therapeutics CBAY Stock Holding History

Millennium Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-200,000
Closed -$872K – 7392
2021
Q2 		$872K Buy
200,000
+100,000
+100% +$443K ﹤0.01% 4788
2021
Q1 		$454K Buy
100,000
+80,000
+400% +$431K ﹤0.01% 4899
2020
Q4 		$115K Hold
20,000
– – ﹤0.01% 4998
2020
Q3 		$145 Buy
+20,000
New +$107K ﹤0.01% 4152

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Millennium Management's CBAY Position: Q1 2024 in Review

Millennium Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 921,330 shares — an estimated $21.8M sold.

Millennium Management first reported a position in CBAY in Q1 2017 and held it in 28 quarters. The position peaked at $25.7M in Q1 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Millennium Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Millennium Management sold 921,330 Cymabay Therapeutics shares in Q1 2024, an estimated $21.8M.
  • Millennium Management first reported a position in Cymabay Therapeutics in Q1 2017 and held it in 28 quarters.
  • Millennium Management's Cymabay Therapeutics position peaked at $25.7M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.